Protagonist Therapeutics, Inc.【PTGX】 研究開発費の推移

機能の使い方
(単位:千ドル) 研究開発費 前年比(%)
1Q25 35,893 +6.4%
3Q24 35,970 +17.3%
2Q24 33,520 +1.0%
1Q24 33,734 +23.0%
3Q23 30,664 +20.7%
2Q23 33,182 -4.1%
1Q23 27,416 -24.5%
3Q22 25,402 -31.3%
2Q22 34,611 +30.9%
1Q22 36,318 +49.8%
3Q21 36,956 +131.0%
2Q21 26,432 +30.5%
1Q21 24,245 +29.2%
3Q20 15,995 -7.5%
2Q20 20,257 +4.7%
1Q20 18,768 +50.8%
3Q19 17,293 +42.4%
2Q19 19,355 +9.1%
1Q19 12,444 -19.0%
3Q18 12,145 +8.7%
2Q18 17,735 +47.7%
1Q18 15,368 +36.2%
3Q17 11,168 +100.8%
2Q17 12,007 +110.8%
1Q17 11,282 -
3Q16 5,561 -
2Q16 5,696 -